PATENT CLAIM ANALYSIS

Application Number: 15874694
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "198000"]

Abstract:
A method for increasing the number of CD4+ T-lymphocytes in the serum of a subject in need of such treatment comprising administering to the subject a pharmaceutical composition comprising an amount of an L-isomer of β-lactam effective to increase the number of CD4+ T-lymphocytes in said patient's serum.

Claim (Index 20):
The method of  claim 14  further comprising administering one or more agent selected from the group consisting of statins, PCSK9 inhibitors, fibrate, niacin, and bile acid sequestrants to said patient.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 86.0
- Lexical Diversity: 1.6129
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13302821', '15478028', '15262618', '11791327', '12139053']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7280866463245531
- 35 USC 102 Novelty (BERT): 0.495157124217739
- Combined Prediction Score: 0.7047936941138717
- Mean Citation Score: 205.960014
- Max Citation Score: 244.18988
- Similarity Product: 186.2661866883064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test